Elevai Biosciences, a Subsidiary of Elevai Labs Inc.,
Filed two patent applications for lead candidate EL-22, covering muscle loss in obese patients as a monotherapy and in combination...
Filed two patent applications for lead candidate EL-22, covering muscle loss in obese patients as a monotherapy and in combination...